Corticotropin-Releasing Factor in Brain: A Role in Activation, Arousal, and Affect Regulation
- 1 November 2004
- journal article
- review article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 311 (2) , 427-440
- https://doi.org/10.1124/jpet.103.052092
Abstract
Organisms exposed to challenging stimuli that alter the status quo inside or outside of the body are required for survival purposes to generate appropriate coping responses that counteract departures from homeostasis. Identification of an executive control mechanism within the brain capable of coordinating the multitude of endocrine, physiological, and functional coping responses has high utility for understanding the response of the organism to stressor exposure under normal or pathological conditions. The corticotropin-releasing factor (CRF)/urocortin family of neuropeptides and receptors constitutes an affective regulatory system due to the integral role it plays in controlling neural substrates of arousal, emotionality, and aversive processes. In particular, available evidence from pharmacological intervention in multiple species and phenotyping of mutant mice shows that CRF/urocortin systems mediate motor and psychic activation, stimulus avoidance, and threat recognition responses to aversive stimulus exposure. It is suggested that affective regulation is exerted by CRF/urocortin systems within the brain based upon the sensitivity of local brain sites to CRF/urocortin ligand administration and the appearance of hypothalamo-pituitary-adrenocortical activation following stressor exposure. Moreover, these same stress neuropeptides may constitute a mechanism for learning to avoid noxious stimuli by facilitating the formation of so-called emotional memories. A conceptual framework is provided for extrapolation of animal model findings to humans and for viewing CRF/urocortin activation as a continuum measure linking normal and pathological states.Keywords
This publication has 113 references indexed in Scilit:
- The Effects of Chronic Treatment with the Mood Stabilizers Valproic Acid and Lithium on Corticotropin-Releasing Factor Neuronal SystemsThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Human Urocortin II, a Selective Agonist for the Type 2 Corticotropin-Releasing Factor Receptor, Decreases Feeding and Drinking in the RatThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Drug Addiction, Dysregulation of Reward, and AllostasisPublished by Springer Nature ,2001
- Reduced Availability of Milk after Central Injections of Corticotropin-Releasing Hormone in Lactating RatsNeuroendocrinology, 1994
- Role of Endogenous Corticotropin Releasing Factor in Mediation of Neuroendocrine and Behavioral Responses to Cholecystokinin Octapeptide Sulfate Ester in RatsNeuroendocrinology, 1993
- Corticotronpin-releasing hormone inhibits maternal behavior and induces pup-killingLife Sciences, 1991
- Central effects of CRF on metabolism and energy balanceNeuroscience & Biobehavioral Reviews, 1990
- Cognitive-Emotional Interactions in the BrainCognition and Emotion, 1989
- Behavioral activation by CRF: Evidence for the involvement of the ventral forebrainLife Sciences, 1987
- Effects of Corticotropin-Releasing Factor and Growth Hormone-Releasing Factor on Sleep and Activity in RatsNeuroendocrinology, 1986